Evidence mapPaperPMID 41358624Full record

ArticleJournal of Alzheimer's disease : JAD2026

Peripheral inflammation in a Canadian cohort of neurodegenerative conditions: Occurrence, determinants, and impact.

Bruna Seixas-Lima, Pedro Rosa-Neto, Natalie A Phillips, Michael Borrie, Carlos Tyler Roncero, Durjoy Lahiri, Dvir Dori, Shaun Eintracht, Howard Chertkow

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bruna Seixas-LimaRotman Research Institute at Baycrest and Baycrest Academy, Toronto, ON, Canada.ORCID 0000-0002-6747-8418
Pedro Rosa-NetoCanadian Consortium on Neurodegeneration in Aging (CCNA), Montreal, QC, Canada.
Natalie A PhillipsCanadian Consortium on Neurodegeneration in Aging (CCNA), Montreal, QC, Canada.ORCID 0000-0003-0855-2961
Michael BorrieCanadian Consortium on Neurodegeneration in Aging (CCNA), Montreal, QC, Canada.
Carlos Tyler RonceroRotman Research Institute at Baycrest and Baycrest Academy, Toronto, ON, Canada.ORCID 0000-0002-8712-0843
Durjoy LahiriDivision of Neurology, Department of Medicine, Queen's University, Kingston Health Sciences Centre Kingston General Hospital Site Connell 7, Kingston, ON, Canada.ORCID 0000-0002-2487-9537
Dvir DoriRotman Research Institute at Baycrest and Baycrest Academy, Toronto, ON, Canada.ORCID 0009-0004-5332-3636
Shaun EintrachtDivision of Medical Biochemistry, Department of Medicine, Jewish General Hospital, Montreal, QC, Canada.
Howard ChertkowRotman Research Institute at Baycrest and Baycrest Academy, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background"Inflammaging" describes chronic low-grade inflammation observed in aging individuals. It may play a major role in neurodegeneration.ObjectiveTo assess blood inflammatory markers in older adults. We hypothesized that elevated inflammation would be found in some cognitively normal older adults but would be more prevalent in individuals with cognitive impairment.MethodsInterleukin-6 (IL-6) and C-reactive protein (CRP) were assessed in 514 Canadian individuals in COMPASS-ND, a detailed study of cognitive impairment in the elderly. Cumulative link model (CLM) was used to investigate the relationship between inflammation status (low, medium, or high tertiles) and demographic and lifestyle factors along with cognitive function and cognitive diagnoses.ResultsWe found that 12% of cognitively normal older adults had IL-6 levels in the highest tertile, but this increased in cognitively impaired cohorts-36% in Alzheimer's disease, 55% mixed dementia, 30% mild cognitive impairment, and 39% vascular mild cognitive impairment. We found that 36% of cognitively unimpaired older individuals display "elevated" IL-6 (middle and high tertile values), while approximately 70% of those with cognitive impairment also do so. Inflammation markers increased most robustly in association with age, higher body mass index, and higher Fazekas (MRI white matter hyperintensity) score. There were also weaker associations with female sex, nutrition, number of comorbidities, and poor sleep.ConclusionsPeripheral low-grade inflammation was common, particularly in individuals with cognitive impairment; and obesity and age were the main drivers. It remains unclear whether treatment targeting such inflammation might have a therapeutic role in dementia prevention.

Indexed as

Cognitive DysfunctionInflammationInterleukin-6Neurodegenerative DiseasesAgedAged, 80 and overBiomarkersCanadaCohort StudiesC-Reactive ProteinFemaleHumansMaleMiddle AgedBiomarkersC-Reactive ProteinIL6 protein, humanInterleukin-6agingAlzheimer's diseasedementiainflammation

Identifiers

PMID41358624
PMCPMC12999994

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.